Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
High-Tc Susceptometer to Monitor Transfusional Iron Overload
- Status
- COMPLETED
- Phase
- N/A
Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Dose-reduced Versus Standard Conditioning in MDS/sAML
- Status
- TERMINATED
- Phase
- PHASE3
Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- PHASE4
An Extension to Study AZA PH GL 2003 CL 001 Allowing for Continuation of Azacitidine Treatment in Patients With Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- PHASE3
Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
- Status
- COMPLETED
- Phase
- PHASE1
Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors
- Status
- COMPLETED
- Phase
- PHASE2
Registry of Older Patients With Cancer
- Status
- RECRUITING
- Phase
- N/A
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- Status
- RECRUITING
- Phase
- N/A
Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Myelodysplastic Syndromes
- Status
- UNKNOWN
- Phase
- PHASE2
Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE2
Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Lenalidomide Combined to Azacitidine in Intermediate-2 or High Risk MDS With Del 5q
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDS
- Status
- TERMINATED
- Phase
- PHASE1
Safety of Lenalidomide and Markers for Disease Progression in Patients With International Prognostic Scoring System (IPSS) Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) With Isolated del5q
- Status
- COMPLETED
- Phase
- PHASE2
Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant
- Status
- TERMINATED
- Phase
- N/A
Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) in Combination With Azacitidine for the Treatment of Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1